Use of Respimat^® Soft Mist™ Inhaler in COPD patients

References

• DalbyRSpallekMVoshaarT2004A review of the development of Respimat® Soft Mist Inhaler™Int J Pharm2831915363496
   PubMed Web of Science ®Google Scholar
• DolovichMBAhrensRCHessDR2005Device selection and outcomes of aerosol therapy: evidence-based guidelinesChest1273357115654001
   PubMed Web of Science ®Google Scholar
• FinkJB2000Metered-dose inhalers, dry powder inhalers, and transitionsResp Care4562335
   PubMedGoogle Scholar
• FinkJBRubinBK2005Problems with inhaler use: a call for improved clinician and patient educationRespir Care5013607416185371
   PubMedGoogle Scholar
• GoldbergJFreundEBeckersB2001Improved delivery of fenoterol plus ipratropium bromide using Respimat® compared with a conventional metered dose inhalerEur Respir J172253211334124
   PubMed Web of Science ®Google Scholar
• HochrainerDHölzHKreherC2005Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist Inhaler™ and pressurized metered dose inhalersJ Aerosol Med182738216181002
   PubMedGoogle Scholar
• HodderRPaviaDDewberryH2005Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat® Soft Mist™ inhalerRespir Med9910879515893465
   PubMed Web of Science ®Google Scholar
• IaconoPVelicitatPGuemasE2000Improved delivery of ipratropium bromide using Respimat® (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPDRespir Med94490710868713
   PubMed Web of Science ®Google Scholar
• KässnerFHodderRBatemanED2004A review of ipratripium bromide/ fenoterol hydrobromide (Berodual®) delivered via Respimat® Soft Mist Inhaler™ in patients with asthma and chronic obstructive pulmonary diseaseDrugs6416718215257628
   PubMed Web of Science ®Google Scholar
• KilfeatherSAPonitzHHBeckE2004Improved delivery of ipratropium bromide/fenoterol from Respimat® Soft Mist™ Inhaler in patients with COPDRespir Med983879715139567
   PubMed Web of Science ®Google Scholar
• KoehlerDPaviaDDewberryH2004Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat® Soft Mist™ Inhaler; results of phase II single-dose crossover studiesRespiration714697615467324
   PubMed Web of Science ®Google Scholar
• KozmaCMSlatonTLMonzBU2005Development and validation of a patient satisfaction and preference questionnaire for inhalation devicesTreat Respir Med4415215725049
   PubMedGoogle Scholar
• KunkelGMagnussenHBergmannKC2000Respimat® (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patientsRespiration673061410867600
   PubMed Web of Science ®Google Scholar
• LeachCL1995Approaches and challenges to use freon propellant replacementsAerosol Sci Technol2232834
   Web of Science ®Google Scholar
• McFaddenER1995Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuseJ Allergy Clin Immunol96278837636071
   PubMed Web of Science ®Google Scholar
• MelaniASZanchettaDBarbatoN2004Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adultsAnn Allergy Asthma Immunol934394615562882
   PubMed Web of Science ®Google Scholar
• NewmanSP2005Inhaler treatment options in COPDEur Respir Rev141023
   Google Scholar
• NewmanSPBrownJSteedSP1998Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicinesChest113957639554631
   PubMed Web of Science ®Google Scholar
• NewmanSPSteedKPReaderSJ1996Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizerJ Pharm Sci8596048877887
   PubMed Web of Science ®Google Scholar
• NewmanSPWeiszAWBTalaeeN2001Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler techniqueThorax46712161750017
   PubMed Web of Science ®Google Scholar
• PitcairnGReaderSPaviaD2005Deposition of corticosteroid aerosol in the human lung by Respimat® Soft Mist™ Inhaler compared to deposition by metered dose inhaler or by Turbuhaler® dry powder inhalerJ Aerosol Med182647216181001
   PubMedGoogle Scholar
• SchürmannWSchmidtmannSMoroniP2005Respimat® Soft Mist™ Inhaler versus hydrofluoroalkane metered dose inhaler. Patient preference and satisfactionTreat Respir Med4536115725050
   PubMedGoogle Scholar
• SpallekMWHochrainerDWachtelH2002Optimizing nozzles for soft mist inhalersRespiratory Drug Delivery VIII23758
   Google Scholar
• SteedKPTowseLJFreundB1997Lung and oropharyngeal deposition of fenoterol hydrobromide delivered from the prototype III hand-held multidose Respimat nebulizerEur J Pharm Sci55561
   Web of Science ®Google Scholar
• Van NoordJASmeetsJJCreemersJPHM2000Delivery of fenoterol via Respimat®, a novel “soft mist” inhalerRespiration67672811124651
   PubMed Web of Science ®Google Scholar
• VinckenWBantjeTMiddleMV2004Long-term efficacy and safety of ipratropium bromide plus fenoterol via Respimat® Soft Mist™ inhaler (SMI) versus a pressurised metered-dose inhaler in asthmaClin Drug Invest241728
   PubMed Web of Science ®Google Scholar
• VinckenWDewberryHMoonenD2003Fenoterol delivery by Respimat® soft mist inhaler versus CFC metered dose inhaler: cumulative dose-response study in asthma patientsJ Asthma407213014580004
   PubMed Web of Science ®Google Scholar
• von BergAJeenaPMSoemantriPA2004Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat® Soft Mist™ inhaler vs. a conventional metered dose inhaler plus spacer in children with asthmaPediatr Pulmonol372647214966821
   PubMed Web of Science ®Google Scholar
• WilkesWFinkJDhandR2001Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhalerJ Aerosol Med133516011693847
   PubMedGoogle Scholar
• WolffRKNivenRW1994Generation of aerosolized drugsJ Aerosol Med78910410147060
   PubMedGoogle Scholar
• ZierenbergGOptimizing the in vitro performance of Respimat. 1999J Aerosol Med12S192410623337
   PubMedGoogle Scholar